Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
in2cure logo — company profile

in2cure

Founded 2013 Sweden Sweden 4 employees Series Unknown Total: $1.00M Biotechnology

General Information

Company Name in2cure
Founded Year 2013
Location Sweden Sweden +1
Employees 4
Industries Biotechnology
Funding Stage Series Unknown
Social

Get notified when in2cure moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About in2cure

In2cure AB, a Swedish biotechnological company founded in 2013, focuses on developing proprietary anti-endotoxic host defense peptides for the prevention and treatment of wound and surgical complications, with a particular emphasis on functionalized biomaterials. The company's lead candidate, TCP-25, is currently in the pre-clinical stage and is derived from nature's own powerful host defense mechanisms activated during wound healing. This multifunctional peptide, discovered at Lund University by Professor Artur Schmidtchen and his team, aims to prevent bacterial infection, reduce complications caused by excessive activation of inflammatory cascades, and rapidly kill microbes through membrane lysis. In2cure's technology provides a unique mechanism of action, allowing strong binding and neutralization of endotoxins, thus preventing activation of inflammatory pathways. The company also explores potential applications for its technologies beyond wound and surgical care. The most recent funding, a kr1.00M Venture Round investment, was secured on 02 October 2018 and came from SmiLe Venture Hub. As an industry player in biotechnology, in2cure is positioned to leverage its innovative approach in addressing critical healthcare challenges related to wound healing and surgical interventions.

Taxonomy: anti-endotoxic peptides, wound healing, surgical complications, functionalized biomaterials, pre-clinical stage, inflammatory pathways, microbial infection, membrane lysis, Lund University, scientific discoveries, host defense mechanisms, novel therapies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
02 Oct 2018

in2cure Alternatives & Competitors

in2cure vs
Parable Health
Parable Health United States

Parable is building the next generation of mobile, computer vision-powered asynchronous telemedicine...

Pre Seed
12 employees
Digital Health, Health Care
in2cure vs
KCI USA
KCI USA

KCI offers a wide range of clinically proven, economically beneficial wound healing therapies and te...

Post Ipo Equity
200 employees
Biotechnology, Health Care
in2cure vs
SANUWAVE
SANUWAVE United States

Heal Wounds With Energy First

Post Ipo Equity
54 employees
Biotechnology, Health Care

FAQ About in2cure

in2cure AB is a biotechnological company developing proprietary anti-endotoxic host defense peptides for prevention and treatment of wound and surgical complications, with a major focus on functionalized biomaterials. in2cure also investigates potential other applications for its technologies. Th...
in2cure was founded in 2013.
in2cure is headquartered in Sweden.
in2cure operates in the following industries: Biotechnology.
in2cure has approximately 4 employees.
in2cure has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to in2cure include Parable Health, KCI USA, SANUWAVE, Suturion, Medsix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
in2cure and Parable Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors in2cure and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes